Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bouscary

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 7, 1998
Ribavirin therapy for cryoglobulinemia and thrombocytopenia associated with hepatitis C virus infectionP Blanche, D Bouscary
Frontiers in Oncology|February 5, 2026
NCOA4 and ferritinophagy in hematological malignancies: a double-edged regulator of iron metabolism and cell fateT Chabane, D Bouscary, E Grignano
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 23, 2018
Nivolumab combined with ruxolitinib: antagonism or synergy?P E Debureaux, J Arrondeau, D Bouscary, et al.
Presse Medicale (Paris, France : 1983)|June 20, 1987
[Serum monoclonal immunoglobulins and HIV-I infection]D Bouscary, R Fior, L Intrator, et al.
Annals of Hematology|October 16, 2012
Neutrophilic myositis sine dermatitis in a neutropenic patient with myelodysplastic syndromeE Mosnier, P Rousset, D Hugol, et al.
Leukemia|August 18, 1999
Successful treatment of acquired factor VIII inhibitor with fludarabine and cyclophosphamide in chronic lymphoid leukemiaP Blanche, D Bouscary, B Gombert, et al.
Leukemia|January 1, 1995
Expression of the Evi-1 gene in myelodysplastic syndromesF Dreyfus, D Bouscary, J Melle, et al.
Leukemia & Lymphoma|March 1, 1995
c-mpl expression in hematologic disordersD Bouscary, C Prudhomme, B Quesnel, et al.
The Journal of Infection|July 25, 2000
Autoimmune haemolytic anaemia revealing miliary tuberculosisP Blanche, A Rigolet, P P Massault, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 12, 2003
Tuberculosis due to Mycobacterium bovis after alemtuzumab administrationS Abad, E Gyan, L Moachon, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 7, 1998
Ribavirin therapy for cryoglobulinemia and thrombocytopenia associated with hepatitis C virus infectionP Blanche, D Bouscary
Frontiers in Oncology|February 5, 2026
NCOA4 and ferritinophagy in hematological malignancies: a double-edged regulator of iron metabolism and cell fateT Chabane, D Bouscary, E Grignano
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 23, 2018
Nivolumab combined with ruxolitinib: antagonism or synergy?P E Debureaux, J Arrondeau, D Bouscary, et al.
Presse Medicale (Paris, France : 1983)|June 20, 1987
[Serum monoclonal immunoglobulins and HIV-I infection]D Bouscary, R Fior, L Intrator, et al.
Annals of Hematology|October 16, 2012
Neutrophilic myositis sine dermatitis in a neutropenic patient with myelodysplastic syndromeE Mosnier, P Rousset, D Hugol, et al.
Leukemia|August 18, 1999
Successful treatment of acquired factor VIII inhibitor with fludarabine and cyclophosphamide in chronic lymphoid leukemiaP Blanche, D Bouscary, B Gombert, et al.
Leukemia|January 1, 1995
Expression of the Evi-1 gene in myelodysplastic syndromesF Dreyfus, D Bouscary, J Melle, et al.
Leukemia & Lymphoma|March 1, 1995
c-mpl expression in hematologic disordersD Bouscary, C Prudhomme, B Quesnel, et al.
The Journal of Infection|July 25, 2000
Autoimmune haemolytic anaemia revealing miliary tuberculosisP Blanche, A Rigolet, P P Massault, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 12, 2003
Tuberculosis due to Mycobacterium bovis after alemtuzumab administrationS Abad, E Gyan, L Moachon, et al.
Pageof 8